1. Home
  2. FULC vs CLAR Comparison

FULC vs CLAR Comparison

Compare FULC & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • CLAR
  • Stock Information
  • Founded
  • FULC 2015
  • CLAR 1957
  • Country
  • FULC United States
  • CLAR United States
  • Employees
  • FULC N/A
  • CLAR N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • CLAR Recreational Games/Products/Toys
  • Sector
  • FULC Health Care
  • CLAR Consumer Discretionary
  • Exchange
  • FULC Nasdaq
  • CLAR Nasdaq
  • Market Cap
  • FULC 210.9M
  • CLAR 173.0M
  • IPO Year
  • FULC 2019
  • CLAR N/A
  • Fundamental
  • Price
  • FULC $3.85
  • CLAR $4.75
  • Analyst Decision
  • FULC Hold
  • CLAR Strong Buy
  • Analyst Count
  • FULC 9
  • CLAR 3
  • Target Price
  • FULC $7.63
  • CLAR $6.33
  • AVG Volume (30 Days)
  • FULC 368.1K
  • CLAR 117.3K
  • Earning Date
  • FULC 02-25-2025
  • CLAR 03-06-2025
  • Dividend Yield
  • FULC N/A
  • CLAR 2.10%
  • EPS Growth
  • FULC N/A
  • CLAR N/A
  • EPS
  • FULC N/A
  • CLAR 0.13
  • Revenue
  • FULC $80,871,000.00
  • CLAR $269,413,000.00
  • Revenue This Year
  • FULC $2,823.78
  • CLAR N/A
  • Revenue Next Year
  • FULC N/A
  • CLAR $9.30
  • P/E Ratio
  • FULC N/A
  • CLAR $37.61
  • Revenue Growth
  • FULC 2987.86
  • CLAR 48.98
  • 52 Week Low
  • FULC $2.86
  • CLAR $3.89
  • 52 Week High
  • FULC $13.70
  • CLAR $7.55
  • Technical
  • Relative Strength Index (RSI)
  • FULC 47.75
  • CLAR 49.18
  • Support Level
  • FULC $3.64
  • CLAR $4.80
  • Resistance Level
  • FULC $3.94
  • CLAR $4.94
  • Average True Range (ATR)
  • FULC 0.18
  • CLAR 0.17
  • MACD
  • FULC 0.02
  • CLAR -0.01
  • Stochastic Oscillator
  • FULC 84.21
  • CLAR 46.81

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a global leader in designing, manufacturing, and marketing innovative outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of highly-engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

Share on Social Networks: